Peritoneal carcinomatosis from ovarian cancer: Role of 18F-FDG-PET/CT and CA125;La carcinosi peritoneale da carcinoma ovarico: Utilità della 18F-FDG-PET/TC e del biomarker CA125

Recenti Progressi in Medicina

Volumn 103, Issue 11, 2012, Pages 510-514

  Rubini, Giuseppe ^a   Altini, Corinna ^a   Notaristefano, Antonio ^a   Merenda, Nunzio ^a   Rubini, Domenico ^a   Stabile Ianora, Antonio Amato ^a   Giganti, Melchiore ^b   Niccoli Asabella, Artor ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

18F FDG PET CT; CA125; Ovarian cancer; Peritoneal carcinomatosis

Indexed keywords

CA 125 ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PERITONEUM CANCER; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 84868270775     PISSN: 00341193     EISSN: 20381840     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ozols R, Ruben S, Thomas G, Robboy S. Epithelial ovarian cancer. In: Oskin WJ (ed). Principles and practice of gynecologic oncology. Fourth ed. Philadelphia: Lippincott Williams & Wilkins 2005, pp. 895-987.
2. Incidence and mortality data of Italian network of Cancer Registers (AIRT) 1998-2002.
3. Del Carmen MG. Primary epithelial ovarian cancer: diagnosis and management. In: Educational book of the American Society of Clinical Oncology (ASCO). Alexandria: American Society of Clinical Oncology, 2006; 330-334.
4. Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM. Peritoneal carcinomatosis: role of (18)F-FDG Pet. J Nucl Med 2003; 44: 1407-12. (Pubitemid 39663352)
5. Bertolini L, Vaglio A, Bignardi L, et al. Subclinical interstitial lung abnormalities in stable renal allograft recipients in the era of modern immunosoppression. Transplant Proc 2011; 43: 2617-23.
6. Scardapane A, Bettocchi S, Lorusso F, et al. Diagnosis of colorectal endometriosis: contribution of contrast enhanced MR-colography. Eur Radiol 2011; 21: 1553-63.
7. Angelelli G, Moschetta M, Sabato L, Morella M, Scardapane A, Stabile Ianora AA. Value of "protruding lips" sign in malignant bowel obstructions. Eur J Radiol 2011; 80: 681-5.
8. Moschetta M, Stabile Ianora AA, Pedote P, et al. Prognostic value of multidetector computed tomography in bowel infarction. Radiol Med 2009; 114: 780-91.
9. Cafagna D, Rubini G, Maggialetti A, et al. Wholebody MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study. Radiol Med 2012; 117: 293-311.
10. Niccoli Asabella A, Altini C, Notaristefano A, et al. Contrast enhancement computed tomography and 18-fluorine-labelled 2-deoxy-2-fluoro-d- glucose Positron Emission Tomography/Computed Tomography correlation in the management of a patient with primary mediastinal seminoma and candidate to liver transplant. Gazzetta Medica Italiana 2011; 174: 449-55.
11. Niccoli Asabella A, Notaristefano A, Pisani AR, et al. Different causes of 18-fluorine-labelled-2-deoxy-2-fluoro-d-glucose uptake in patient with non hodgkin lymphoma. Gazzetta Medica Italiana 2012; 171: 351-6.
12. 99mTc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease. Hell J Nucl Med 2011; 14: 311-2.
13. Asabella An, Gatti P, Notaristefano A, et al. F-18 FDG PET/CT in the diagnosis of a rare case of neurosarcoidosis in a patient with diabetes insipidus. Clin Nucl Med 2011; 36: 795-7.
14. Lutz AM, Willmann JK, Drescher CW, Gambhir SS, et al. Early diagnosis of ovarian carcinoma: is a solution in sight? Radiology 2011; 259: 329-45.
15. Mazzei MA, Mazzei FG, Marrelli D. Computed Tomographic evaluation of mesentery: diagnostic value in acute mesenteric ischemia. J Comput Assist Tomogr 2012; 30: 1-7.
16. Pannu HK, Cohade C, Bristow RE, et al. PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation. Abdom Imaging 2004; 29: 398-403. (Pubitemid 38590822)
17. Coakley FV, Choi PH, Cougoutas CA, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 2002; 223: 495-9. (Pubitemid 34454332)
18. Suzuki A, Kawano T, Takahashi N, et al. Value of 18F-FDG-PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Imaging 2004; 31; 1413-20. (Pubitemid 39361938)
19. Thrall MM, Deloia J, Gallion H, Avril N. Clinical use of combined Positron Emission Tomography and Computed Tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecol Oncol 2007; 105: 17-22. (Pubitemid 46441448)
20. Simcock B, Neesham D, Quinn M, Drummond E, Milner A, Hicks RJ. The impact of PET/CT in the management of recurrent ovarian cancer. Gynecol Oncol 2006; 103: 271-6. (Pubitemid 44374699)
21. Pusiol T, Zorzi Mg, Morichetti D, et al. Uselessness of percutaneous core needle renal biopsy in the management of small renal masses. Urol Int 2011; 87: 125-6.
22. Pusiol T, Franceschetti I, Scialpi M, et al. Incidental necrotizing paratubal granuloma associated with multiple neoplasms. J Gynecol Surg 2011; 27: 29-32.
23. Volterrani L, Mazzei MA, Banchi B, et al. MSCT multi-criteria: a novel approach in assessment of mediastinal lymph node metastases in non-small cell lung cancer. Eur J Radiol 2011; 79: 459-66.
24. Correale P, Remondo C, Carbone SF, et al. Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients. Cancer Biol Ther 2010; 9: 685-93.
25. Roviello F, Pinto E, Corso G, et al. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer. J Surg Oncol 2010; 102: 663-70.
26. Marrelli D, Mazzei MA, Petrazzani C, et al. High accuracy of Multislice Computed Tomography (MSCT) for para-aortic lymph nodes metastases from gastric cancer: a prospective single-center study. Ann Surg Oncol 2011; 18: 2265-72.
27. Pusiol T, Zorzi MG, Morichetti G, et al. Synchronous nonfunctional duodenal carcinoid and high risk gastrointestinal stromal tumour (GIST) of the stomach. Eur Rev Med Pharmacol Sci 2011; 15: 583-5.
28. Pusiol T, Zorzi MG, Morichetti D, et al. Uselessness of percutaneous core needle renal biopsy in the management of small renal masses. Urol Int 2011; 87: 125-6.